Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells

British Journal of Haematology

Volumn 151, Issue 4, 2010, Pages 327-335

  Choudhury, Aniruddha ^a   Derkow, Katja ^a   Daneshmanesh, Amir Hossein ^a   Mikaelsson, Eva ^a   Kiaii, Shahryar ^a   Kokhaei, Parviz ^a   Österborg, Anders ^a,b   Mellstedt, Håkan ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Chronic lymphocytic leukaemia; FMOD; ROR1; Silencing; SiRNA

Indexed keywords

FIBROMODULIN; MESSENGER RNA; SMALL INTERFERING RNA;

B LYMPHOCYTE; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FMOD GENE; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; ROR1 GENE;

APOPTOSIS; EXTRACELLULAR MATRIX PROTEINS; GENE SILENCING; GENES, NEOPLASM; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; NEOPLASM PROTEINS; PROTEOGLYCANS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 77958519836     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08362.x     Document Type: Review

References (24)

1. Baskar, S., Kwong, K.Y., Hofer, T., Levy, J.M., Kennedy, M.G., Lee, E., Staudt, L.M., Wilson, W.H., Wiestner, A. & Rader, C. (2008) Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia. Clinical Cancer Research, 14, 396-404.
2. Burger, J.A. & Kipps, T.J. (2002) Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells. Leukaemia and Lymphoma, 43, 461-466.
3. Burger, J.A., Tsukada, N., Burger, M., Zvaifler, N.J., Dell'Aquila, M. & Kipps, T.J. (2000) Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood, 96, 2655-2663.
4. Collins, R.J., Verschuer, L.A., Harmon, B.V., Prentice, R.L., Pope, J.H. & Kerr, J.F. (1989) Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. British Journal of Haematology, 71, 343-350.
5. Daneshmanesh, A.H., Mikaelsson, E., Jeddi-Tehrani, M., Bayat, A.A., Ghods, R., Ostadkarampour, M., Akhondi, M., Lagercrantz, S., Larsson, C., Osterborg, A., Shokri, F., Mellstedt, H. & Rabbani, H. (2008) Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy. International Journal of Cancer, 123, 1190-1195.
6. Fukuda, T., Chen, L., Endo, T., Tang, L., Lu, D., Castro, J.E., Widhopf, G.F. 2nd, Rassenti, L.Z., Cantwell, M.J., Prussak, C.E., Carson, D.A. & Kipps, T.J. (2008) Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proceedings of the National Academy of Sciences of the USA, 105, 3047-3052.
7. Giannopoulos, K., Li, L., Bojarska-Junak, A., Rolinski, J., Dmoszynska, A., Hus, I., Greiner, J., Renner, C., Dohner, H. & Schmitt, M. (2006) Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia. International Journal of Oncology, 29, 95-103.
8. Grdisa, M. (2003) Influence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro. Leukemia Research, 27, 951-956.
9. Hedbom, E. & Heinegard, D. (1989) Interaction of a 59-kDa connective tissue matrix protein with collagen I and collagen II. Journal of Biological Chemistry, 264, 6898-6905.
10. Hildebrand, A., Romaris, M., Rasmussen, L.M., Heinegard, D., Twardzik, D.R., Border, W.A. & Ruoslahti, E.. (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochemical Journal, 302 (Pt 2), 527-534.
11. Hus, I., Schmitt, M., Tabarkiewicz, J., Radej, S., Wojas, K., Bojarska-Junak, A., Schmitt, A., Giannopoulos, K., Dmoszynska, A. & Rolinski, J. (2008) Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8 + T cells as well as CD4 + CD25 + FoxP3 + regulatory T cells toward an antileukemia response. Leukemia, 22, 1007-1017.
12. Jelinek, D.F., Tschumper, R.C., Stolovitzky, G.A., Iturria, S.J., Tu, Y., Lepre, J., Shah, N. & Kay, N.E. (2003) Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Molecular Cancer Research, 1, 346-361.
13. Klein, U., Tu, Y., Stolovitzky, G.A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., Neri, A., Califano, A. & Dalla-Favera, R. (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. Journal of Experimental Medicine, 194, 1625-1638.
14. Lotz, M., Ranheim, E. & Kipps, T.J. (1994) Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. Journal of Experimental Medicine, 179, 999-1004.
15. MacKeigan, J.P., Murphy, L.O. & Blenis, J. (2005) Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nature Cell Biology, 7, 591-600.
16. Mayr, C., Bund, D., Schlee, M., Moosmann, A., Kofler, D.M., Hallek, M. & Wendtner, C.M. (2005) Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8 + autologous T lymphocytes. Blood, 105, 1566-1573.
17. Mikaelsson, E., Danesh-Manesh, A.H., Luppert, A., Jeddi-Tehrani, M., Rezvany, M.R., Sharifian, R.A., Safaie, R., Roohi, A., Osterborg, A., Shokri, F., Mellstedt, H. & Rabbani, H. (2005) Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Blood, 105, 4828-4835.
18. Oldberg, A., Antonsson, P., Lindblom, K. & Heinegard, D. (1989) A collagen-binding 59-kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG-S1 and PG-S2 (decorin). EMBO Journal, 8, 2601-2604.
19. Pedersen, I.M., Kitada, S., Leoni, L.M., Zapata, J.M., Karras, J.G., Tsukada, N., Kipps, T.J., Choi, Y.S., Bennett, F. & Reed, J.C. (2002) Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood, 100, 1795-1801.
20. Reddy, U.R., Phatak, S. & Pleasure, D. (1996) Human neural tissues express a truncated Ror1 receptor tyrosine kinase, lacking both extracellular and transmembrane domains. Oncogene, 13, 1555-1559.
21. Rezvany, M.R., Jeddi-Tehrani, M., Rabbani, H., Lewin, N., Avila-Carino, J., Osterborg, A., Wigzell, H. & Mellstedt, H. (2000) Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia. British Journal of Haematology, 111, 608-617.
22. Soo, C., Hu, F.Y., Zhang, X., Wang, Y., Beanes, S.R., Lorenz, H.P., Hedrick, M.H., Mackool, R.J., Plaas, A., Kim, S.J., Longaker, M.T., Freymiller, E. & Ting, K. (2000) Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. American Journal of Pathology, 157, 423-433.
23. Vallat, L., Magdelenat, H., Merle-Beral, H., Masdehors, P., Potocki de Montalk, G., Davi, F., Kruhoffer, M., Sabatier, L., Orntoft, T.F. & Delic, J. (2003) The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays. Blood, 101, 4598-4606.
24. Yoda, A., Oishi, I. & Minami, Y. (2003) Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans. Journal of Receptor and Signal Transduction Research, 23, 1-15.